✦ LIBER ✦

Developing a laser safety program

✍ Scribed by Greg Sackett

Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 134 KB
Volume: 9
Category: Article
ISSN: 1074-9098
DOI: 10.1016/s1074-9098(02)00313-1

No coin nor oath required. For personal study only.

✦ Synopsis

Developing a laser safety program

As the use of lasers becomes more prevalent in the workplace, the importance of a comprehensive laser safety program continues to increase. As safety professionals, we may be tasked with investigating the need for a laser safety program and if necessary, developing a program. While the structure of a laser safety program will vary with the needs of the institution, there are some common themes that should be explored to determine if they are applicable to a particular program. Additionally, several potential obstacles to program development should be investigated in order to develop methods of solving or avoiding problems.

📜 SIMILAR VOLUMES

Program development for safety tests

✍ L. Hub; T. Kupr; E. Staeheli 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 269 KB

New developments in laser safety

✍ DavidH. Sliney 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Red laser development program

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Dow Corning Corp has formed Compound Semiconductor Solutions (CSS), a new business to serve the wide band gap semiconductor industry. Located in Midland, MI, CCS incorporates Dow's many years of in-house and academic research investment, plus the recent acquisitions of business and technology assets

Defining, developing and operating an ef

Defining, developing and operating an effective safety and health program

✍ Sixto R. Mendez 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 235 KB

Overview of the Board of Laser Safety's

Overview of the Board of Laser Safety's professional certification programs for Laser Safety Officers

✍ Ben Edwards; Barbara Sams 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 147 KB

The OptiMARK clinical development progra

The OptiMARK clinical development program: Summary of safety data

✍ Jeffrey J. Brown; Rita M. Kristy; Gary R. Stevens; Joseph A. Pierro 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract ## Purpose To describe and summarize the safety data from the OptiMARK clinical development program. ## Materials and Methods In the 18 clinical studies comprising the clinical program, doses ranging from 0.1 to 0.7 mmol/kg were administered to healthy adult volunteers, patients with